Further, dysregulation of the BCR signaling in CLL is characterized by constitutively active phosphorylation of certain kinases, such as Lyn and Syk that also triggers cell survival pathways. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.